HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG
Approved
DIN Number
02243562
Drug Class
Human
Market Date
Jul 3, 2001
Company
HC
purdue pharma
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243562
AIG Number0108698015
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA03 HYDROMORPHONE
Product Specifications
Dosage FormCapsule (Sustained-Release)
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
HYDROMORPHONE HYDROCHLORIDEActive
Strength: 18 MG
Monograph: HYDROMORPHONE HYDROCHLORIDE